Business Description
ContextVision AB
ISIN : SE0014731154
Total Employee Number:
43Compare
Compare
Traded in other countries / regions
CONTX.NorwayCOVo.Sweden0L8Z.UK IPO Date
1997-03-17Description
ContextVision AB is a medical technology company. It develops and sells image enhancement software for medical diagnosis and artificial intelligence. Its product portfolio includes image enhancement software for 2D/3D/4D (dimensional) ultrasound, magnetic resonance imaging (MRI), X-Ray, radiography, and mammography. Its geographical segments are Asia, Europe, and America.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 5.88 | |||||
Equity-to-Asset | 0.72 | |||||
Debt-to-Equity | 0.13 | |||||
Debt-to-EBITDA | 0.89 | |||||
Interest Coverage | 6.69 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 6.11 | |||||
Beneish M-Score | -2.8 | |||||
WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 2.9 | |||||
3-Year EBITDA Growth Rate | -44.5 | |||||
3-Year EPS without NRI Growth Rate | -70 | |||||
3-Year FCF Growth Rate | -77.4 | |||||
3-Year Book Growth Rate | 17.5 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate Industry Rank | 164.41 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 2.23 |
Momentum Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 59.2 | |||||
9-Day RSI | 54.64 | |||||
14-Day RSI | 52.59 | |||||
3-1 Month Momentum % | 1.52 | |||||
6-1 Month Momentum % | -20.05 | |||||
12-1 Month Momentum % | -32.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.79 | |||||
Quick Ratio | 3.74 | |||||
Cash Ratio | 2.57 | |||||
Days Inventory | 176.66 | |||||
Days Sales Outstanding | 87.01 | |||||
Days Payable | 497.18 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.8 | |||||
Shareholder Yield % | -0.94 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 97.36 | |||||
Operating Margin % | 2.7 | |||||
Net Margin % | 4.23 | |||||
EBITDA Margin % | 11.46 | |||||
FCF Margin % | 4.75 | |||||
OCF Margin % | 7.52 | |||||
ROE % | 5.23 | |||||
ROA % | 3.87 | |||||
ROIC % | 5.15 | |||||
3-Year ROIIC % | -286.09 | |||||
ROC (Joel Greenblatt) % | 21.39 | |||||
ROCE % | 5.83 | |||||
Years of Profitability over Past 10-Year | 7 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 55.16 | |||||
Forward PE Ratio | 33 | |||||
PE Ratio without NRI | 25.58 | |||||
Shiller PE Ratio | 23.99 | |||||
Price-to-Owner-Earnings | 69.22 | |||||
PS Ratio | 2.24 | |||||
PB Ratio | 2.79 | |||||
Price-to-Tangible-Book | 2.85 | |||||
Price-to-Free-Cash-Flow | 47.07 | |||||
Price-to-Operating-Cash-Flow | 29.66 | |||||
EV-to-EBIT | 33.57 | |||||
EV-to-Forward-EBIT | 75.57 | |||||
EV-to-EBITDA | 15 | |||||
EV-to-Forward-EBITDA | 39.77 | |||||
EV-to-Revenue | 1.72 | |||||
EV-to-Forward-Revenue | 7.06 | |||||
EV-to-FCF | 36.17 | |||||
Price-to-GF-Value | 0.69 | |||||
Price-to-Projected-FCF | 1.05 | |||||
Price-to-Median-PS-Value | 0.4 | |||||
Price-to-Graham-Number | 1.8 | |||||
| Price-to-Net-Current-Asset-Value | 3.84 | |||||
| Price-to-Net-Cash | 7.51 | |||||
Earnings Yield (Greenblatt) % | 2.98 | |||||
FCF Yield % | 2.15 | |||||
Forward Rate of Return (Yacktman) % | -19.82 |
ContextVision AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
ContextVision AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| Third quarter earnings conference call for 2026 | 2026-11-05 | In 129 days | ||
| Third quarter earnings results for 2026 | 2026-11-05 | In 129 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-27 | In 59 days | ||
| Second quarter earnings results for 2026 | 2026-08-27 | In 59 days | ||
| General meeting for 2025 | 2026-05-12 14:00 | 3.65 (-8.06%) | ||
| First quarter earnings conference call for 2026 | 2026-05-08 | 3.62 (+5.23%) | ||
| First quarter earnings results for 2026 | 2026-05-08 | 3.62 (+5.23%) | ||
| Annual report for 2025 | 2026-04-17 | 3.40 (-2.86%) | ||
| Fourth quarter earnings conference call for 2025 | 2026-02-19 | 3.30 (+2.80%) | ||
| Fourth quarter earnings results for 2025 | 2026-02-19 | 3.30 (+2.80%) |
Show
Entries
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on ContextVision AB
No articles.